Clinical trial vials

Clinical trial vials are standardized containers used to store and administer experimental medications in human research.

About this subject

Clinical trial vials are essential components in pharmaceutical research, designed to ensure the integrity and safety of test compounds. Typically made from type I borosilicate glass or high-barrier polymers, these containers must meet rigorous stability and chemical compatibility standards. Each batch is numbered and labeled with unique identification codes, enabling traceability from production to patient administration.

In the United States, the FDA mandates strict packaging requirements for investigational drugs under 21 CFR Part 211. Clinical trial vials often feature tamper-evident closures (aluminum caps or security seals) to prevent adulteration. Volume choices range from 1 mL ampoules for injectable doses to 50 mL vials for intravenous infusions, each selected based on dosing regimens and drug stability.

Historically, standardized vials revolutionized clinical studies. Before the 1960s, many drugs were stored in improvised containers, leading to inconsistent results. After the thalidomide disaster (1957-1962), international regulatory agencies demanded greater quality control. Today, vials frequently incorporate QR codes and electronic labels for integration with data management systems.

Interestingly, glass color serves a specific purpose: amber or green glass protects light-sensitive compounds from UV degradation. Clinical trial vials are single-use for safety reasons, generating waste that requires controlled incineration. Specialized companies like Schott and Gerresheimer dominate global production of these critical items for medical research.

Frequently Asked Questions

Why are clinical trial vials often amber-colored?

Amber glass protects light-sensitive drugs from UV degradation, ensuring compound stability during the study.

What regulations govern clinical trial vial packaging in the US?

The FDA requires compliance with 21 CFR Part 211, which mandates tamper-evident closures, proper labeling, and traceability for investigational drugs.

Can clinical trial vials be reused?

No. They are single-use containers disposed of after administration to prevent cross-contamination and maintain data integrity.